← Back to Search

Behavioural Intervention

VR Interventions for Social Anxiety Disorder (BVR-100-102 Trial)

N/A
Waitlist Available
Research Sponsored by Sumitomo Pharma America, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 6, week 8 (eos)
Awards & highlights

BVR-100-102 Trial Summary

This trial will compare two VR treatments to help people with Social Anxiety Disorder (SAD). #VR #SAD

Who is the study for?
This trial is for adults over 18 with Social Anxiety Disorder who can read and speak English. They must score at least 70 on the Liebowitz Social Anxiety Scale. People with significant sensory impairments, recent substance abuse, certain psychiatric conditions, or those who've had specific treatments like ketamine within a year are excluded.Check my eligibility
What is being tested?
The study compares two self-guided Virtual Reality interventions, BVR-100 and BES-100, to see which is more effective in treating Social Anxiety Disorder when used at home by participants.See study design
What are the potential side effects?
Potential side effects may include discomfort from VR headset use such as motion sickness or nausea due to the immersive nature of virtual reality experiences.

BVR-100-102 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 6, week 8 (eos)
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 6, week 8 (eos) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The measurement of intervention credibility and expectancy of benefit, assessed with the Credibility / Expectancy Questionnaire (CEQ) scores
Secondary outcome measures
subject retention of BVR-100 and BES-100
time-on-task of BVR-100 and BES-100

BVR-100-102 Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: BVR-100Experimental Treatment1 Intervention
Experimental at-home VR intervention for the treatment of SAD
Group II: BES-100Active Control1 Intervention
Active at-home VR intervention comparator
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BVR-100
2023
N/A
~60

Find a Location

Who is running the clinical trial?

BehaVR LLCIndustry Sponsor
2 Previous Clinical Trials
162 Total Patients Enrolled
Sumitomo Pharma America, Inc.Lead Sponsor
236 Previous Clinical Trials
52,664 Total Patients Enrolled
Robert Hayes, PhDStudy DirectorSumitomo Pharma America, Inc.
1 Previous Clinical Trials
231 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research effort enrolling elderly participants?

"In accordance with the trial's guidelines, participants must be between 18 and 99 years old to qualify for enrollment."

Answered by AI

How many people are currently participating in this experimental research?

"Affirmative. According to the data provided on clinicaltrials.gov, this trial was first advertised in September 15th 2023 and has recently been updated on the 25th of same month. 40 volunteers are needed across 3 sites for participation in the study."

Answered by AI

Is it possible for me to partake in this medical experiment?

"This medical trial is seeking 40 individuals with DSM-5 diagnosed social anxiety disorder, aged 18 years or older, who possess English language fluency and literacy. All candidates must present a total Liebowitz Social Anxiety Scale (LSAS) score of at least 70 points during screening."

Answered by AI

Is this research endeavor currently seeking participants?

"Affirmative, there is information available on clinicaltrials.gov that confirms this medical trial's recruitment status. It was first listed in September 15th 2023 and has been updated as recently as the 25th of the same month. This study requires 40 participants from 3 different sites to be enrolled."

Answered by AI
~35 spots leftby Apr 2025